Dr. Bernard Irwin Raskin, MD

Dr. Raskin practices at Aesthetic Surgery & Laser Medical Center in Valencia, California.

Dr. Raskin's NPI, 1013941962, was assigned on July 10, 2006. Dr. Raskin graduated from UC Irvine School of Medicine in 1976. Dr. Raskin holds California license G34720.

Dr. Raskin's primary practice is Aesthetic Surgery & Laser Medical Center, at 28212 Kelly Johnson Pkwy, Suite 265, Valencia, CA 91355. The practice phone is (661) 254-3686.

Dr. Raskin's primary practice is Aesthetic Surgery & Laser Medical Center in Valencia, California. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Raskin to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raskin practices. Vendor and product names are available with a free account.

Dermatology is Dr. Raskin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Raskin is board certified in dermatology by the American Board of Dermatology. Dr. Raskin is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Raskin treats.

CMS data shows 2,896 Medicare services from Dr. Raskin across 18 procedure codes in 2024, for 709 Medicare patients. Medicare paid $172,105 for them.

CMS counts 709 Medicare patients who saw Dr. Raskin in 2024. The largest group is 65 to 74, with 363 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 8% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Raskin's median patient age at 51, with 59% women.

In 2024, Dr. Raskin wrote 373 Medicare Part D claims for 147 patients. 92% of them were for generic drugs. CMS names the drug for 237 of them, across 11 drugs with 11 or more claims each, at $3,394 in total drug cost. In 2023, CMS named 256 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Raskin for performance year 2024, reported individually. Dr. Raskin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 812 procedures of removal of skin lesions by Dr. Raskin, more than 91% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Raskin in 2022. Dr. Raskin's most frequent co-authors are Anne Lynn Su Chang, MD, Gary Rogers, MD and Aleksandar Sekulic, MD.

CMS Open Payments shows 327 general payments to Dr. Raskin from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Genentech, Inc. paid the most, $35,651. It also lists 1 research payment totaling $1,350 in 2022.

Dmand AI lists 3 awards for Dr. Raskin, most recently CMS Stage 1 EHR in 2012.

Dr. Raskin graduated from UC Irvine School of Medicine in 1976. Dr. Raskin is a member of AAD and ASDS.

Dr. Raskin is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.